Compare TRUE & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRUE | OSUR |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.2M | 174.3M |
| IPO Year | 2014 | 1986 |
| Metric | TRUE | OSUR |
|---|---|---|
| Price | $2.27 | $2.43 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $2.55 | ★ $3.00 |
| AVG Volume (30 Days) | ★ 741.3K | 688.5K |
| Earning Date | 02-17-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $181,222,000.00 | $125,703,000.00 |
| Revenue This Year | $9.14 | N/A |
| Revenue Next Year | $7.47 | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.18 | N/A |
| 52 Week Low | $1.05 | $2.08 |
| 52 Week High | $3.83 | $4.22 |
| Indicator | TRUE | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 53.95 | 46.51 |
| Support Level | $2.29 | $2.41 |
| Resistance Level | $2.35 | $2.50 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 54.72 | 23.73 |
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.